Shape 21 Experience
Helpdesk
    Log inRegister
    Shape 21 Experience
    1. Siemens Healthineers Events
    2. Siemens Healthineers Shape 21 AACC Experience
    3. Point of Care Testing

    Point of Care Testing

    Delivering real-time solutions for COVID-19

    In the midst of a global health crisis, particularly one involving a highly contagious virus like SARS-CoV-2, fast results at the point of care can enable healthcare professionals and patients to make informed decisions that help slow the spread of COVID-19 and even save lives. 

    On-site actionable results can make a difference

    From rapid antigen and antibody tests, to blood gas solutions, to our comprehensive portfolio of products for monitoring cardiac, metabolic, and kidney function—our point of care solutions are everywhere where rapid, real-time results are needed.

    Siemens Healthineers Point of Care is committed to providing our customers with the resources and diagnostic tools they need to care for their patients during this challenging global pandemic and beyond.

    End to End Blood Gas Epoc Images

    Rapid Antibody and Antigen Testing

    SARS-CoV-2 IgM/IgG Rapid Antibody Test:

    • Detects whether an individual has had an immune response to a recent or prior infection to the SARS-CoV-2 virus.
    • Finger stick sample collection and visual read—no instrumentation needed.

    CLINITEST® Rapid COVID-19 Antigen Test:

    • Detects the presence of SARS-CoV-2 to quickly identify individuals with active infections.
    • Easily administered by a trained professional without specialized laboratory equipment or lab personnel. 


    *POC Rapid Tests are distributed by Siemens Healthineers. Not available for sale in the U.S. Product availability varies by country.
    End-to-End Blood Gas Epoc Images

    End-to-end Blood Gas Solutions

    Our handheld and benchtop blood gas products, whether in a laboratory or with bedside testing, are being used every day in the care of ventilator-assisted patients. 
    • COVID-19 patients who display respiratory symptoms usually have abnormally low blood oxygen levels. 
    • Treatment includes administration of supplemental oxygen and, in severe cases, mechanical ventilation to aid breathing and oxygenation. 
    • Accurate measurement of blood gases, particularly oxygen, plays a critical role in evaluating and managing patients infected with COVID-19. 
    • The RAPIDPoint® 500e, RAPIDPoint® 500, RAPIDLab® 348 EX*, and RAPIDLab® 1200 Blood Gas Systems and the handheld epoc® Blood Analysis System all offer blood gas and other test parameters for use in a complete range of clinical settings.
    *Not available for sale in the U.S. Product availability varies by country
    COVID-19 pie chart

    Chronic Disease Solutions

    Studies have shown that patients with chronic conditions are at greater risk for more severe complications and worse outcomes if they contract COVID-19.1-4 

    Our portfolio of operator-friendly, trustworthy, and versatile analyzers can: 

    • Help monitor diabetes via a quick, fingerstick test with results in minutes. 
    • Assess kidney function, which is affected by COVID-19, with a simple urine strip.

    Register for the full Siemens Healthineers Shape 21 Experience​

    Engage in one-on-one conversations, have exclusive access to our experts, and participate in live demonstrations of our groundbreaking, new innovations in imaging, diagnostics and therapy.

    Register now for our Siemens Healthineers Events platform to personalize your experience and explore on your own terms.

    Log inRegister

    Product availability may vary from country to country and is subject to varying regulatory requirements. Please contact your local representative for availability.

    1

    Knights H, Mayor N, Millar K, et al. Characteristics and outcomes of patients with COVID-19 at a district general hospital in Surrey, UK. Clinical Medicine. 2020Sep;20(5).

    2

    Rovere-Querini P, De Lorenzo R, Conte C, et al. Post-COVID-19 follow-up clinic: depicting chronicity of a new disease. Acta Biomed. 2020;91(Suppl 9):22-8.

    3

    Wang Z, Du Z, Zhu F. Glycosylated hemoglobin is associated with systemic inflammation, hypercoagulability, and prognosis of COVID-19 patients. Diabetes Res Clin Pract. 2020;164:108214. https://doi.org/10.1016/j.diabres.2020.108214.

    4

    Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395;1054-62.  

    Register